マイクロ流体免疫測定の市場規模、シェア、成長分析、製品別、技術別、用途別、エンドユーザー別、地域別 - 産業予測、2025～2032年

マイクロ流体免疫測定の世界市場規模は、2023年に12億米ドルと評価され、2024年の12億9,000万米ドルから2032年には23億6,000万米ドルに成長し、予測期間（2025-2032年）のCAGRは7.8％で成長する見通しです。

マイクロ流体免疫測定市場は、特に資源が限られた環境において、費用対効果が高く、ハイスループットなポイントオブケア（POC）診断薬に対する需要の高まりに牽引され、急成長を遂げています。POC検査は、人口動態の変化や救急医療における迅速な意思決定の必要性によって拍車がかかり、病院や診療所、さらには自宅での検査にも普及しつつあります。サンプルの前処理が必要であったり、既存の装置では結果が一定しなかったりといった現在の課題にもかかわらず、最小限の試薬使用で正確かつ定量的な結果を提供するラボオンチップ（LOC）技術への関心が高まっています。この動向は、ベンチャーキャピタルからの多額の投資、マイクロ流体技術の継続的な研究、高齢化社会における慢性疾患の蔓延によって後押しされており、LOCは免疫診断におけるゲームチェンジャーとして位置づけられています。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次データと一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• ケーススタディ分析

マイクロ流体免疫測定市場規模：製品別

• 市場概要
• 消耗品
• カートリッジ
• ポリマー
• ガラス
• シリコン
• 試薬
• システム

マイクロ流体免疫測定市場規模：技術別

• 市場概要
• 電気化学検出
• 光学検出

マイクロ流体免疫測定市場規模：用途別

• 市場概要
• 心臓病学
• 単一バイオマーカー検出
• 多重バイオマーカー検出
• 感染症
• 腫瘍学
• その他の用途

マイクロ流体免疫測定市場規模：エンドユーザー別

• 市場概要
• 製薬・バイオテクノロジー企業
• 診断検査室
• 病院
• その他のエンドユーザー

マイクロ流体免疫測定市場規模

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 市場の最近の動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 会社概要
  • 製品ポートフォリオ分析
  • セグメント別シェア分析
  • 収益の前年比比較（2022-2024）

主要企業プロファイル

• Abbott Laboratories（US）
• Bio-Rad Laboratories（US）
• Becton, Dickinson and Company（US）
• Danaher Corporation（US）
• Fluidigm Corporation（US）
• GE Healthcare（US）
• Illumina Inc.（US）
• Luminex Corporation（US）
• Merck Millipore（Germany）
• PerkinElmer Inc.（US）
• Randox Laboratories Ltd.（UK）
• Roche Diagnostics（Switzerland）
• Siemens Healthineers AG（Germany）
• Thermo Fisher Scientific Inc.（US）
• Tosoh Corporation（Japan）
• Wako Pure Chemical Industries, Ltd.（Japan）
• Waters Corporation（US）

結論と推奨事項

Global Microfluidic Immunoassay Market size was valued at USD 1.2 billion in 2023 and is poised to grow from USD 1.29 billion in 2024 to USD 2.36 billion by 2032, growing at a CAGR of 7.8% during the forecast period (2025-2032).

The microfluidic immunoassay market is experiencing rapid growth, driven by the increasing demand for cost-effective, high-throughput point-of-care (POC) diagnostics, especially in resource-limited settings. POC tests are becoming more prevalent in hospitals, clinics, and even at-home testing, spurred by demographic changes and the need for faster decision-making in emergency care. Despite current challenges, such as the need for sample pre-treatment and inconsistent results from existing devices, there is rising interest in lab-on-a-chip (LOC) technology, which offers precise, quantitative results with minimal reagent use. This trend is bolstered by substantial venture capital investments, ongoing research in microfluidic technology, and the growing prevalence of chronic diseases among an aging population, positioning LOC as a game-changer in immunodiagnostics.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Microfluidic Immunoassay market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Microfluidic Immunoassay Market Segmental Analysis

Global Microfluidic Immunoassay Market is segmented by Product, Technology, Application, End User and region. Based on Product, the market is segmented into Consumables, Cartridges, Polymer, Glass, Silicon, Reagents and Systems. Based on Technology, the market is segmented into Electrochemical Detection and Optical Detection. Based on Application, the market is segmented into Cardiology, Single Biomarker Detection, Multiplexed Biomarker Detection, Infectious Diseases, Oncology and Other Applications. Based on End User, the market is segmented into Pharmaceutical & Biotechnology Companies, Diagnostic Laboratories, Hospital and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Microfluidic Immunoassay Market

The microfluidic immunoassay market is poised for significant growth driven by the advent of innovative technologies and the potential of emerging economies. The introduction of novel advancements, such as paper-based microfluidics, is expected to unlock numerous growth opportunities for industry players. Boosted by factors like an aging population, a large patient base with infectious and non-communicable diseases, increased funding for research and development, and a heightened demand for quality healthcare services, these economies are witnessing substantial progress. Furthermore, rising disposable incomes and enhanced healthcare infrastructure are contributing to the market's expansion, creating an optimistic outlook for the sector.

Restraints in the Global Microfluidic Immunoassay Market

The Global Microfluidic Immunoassay market faces various restraints that could impede its growth, particularly in developing nations. Key challenges include the difficulty in selecting appropriate substrate materials for microfluidic chip fabrication, securing reimbursement for these technologies, and scaling up production for widespread availability. Additionally, the lack of affordable options poses a significant barrier, as low-cost products are essential for adoption in underdeveloped regions. These issues contribute to limited accessibility and availability, ultimately hindering the overall market potential in countries where healthcare resources are constrained. Addressing these challenges will be crucial for the market's expansion.

Market Trends of the Global Microfluidic Immunoassay Market

The Global Microfluidic Immunoassay market is witnessing a significant upward trend, driven by the increasing adoption of lab-on-a-chip (LOC) technologies that streamline diagnostic processes by integrating multiple laboratory functions onto a compact platform. This shift eliminates the necessity for cumbersome equipment, enhancing accessibility and efficiency, particularly in point-of-care (POC) settings. Furthermore, the popularity of paper-based microfluidics is rising, especially in developing regions, due to its cost-effectiveness, versatility, and reliance on capillary action for fluid management. With extensive commercial and academic research advancing this field, the market is poised for substantial growth as it increasingly supports rapid diagnostics and personalized medicine.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Study Analysis

Global Microfluidic Immunoassay Market Size by Product & CAGR (2025-2032)

• Market Overview
• Consumables
• Cartridges
• Polymer
• Glass
• Silicon
• Reagents
• Systems

Global Microfluidic Immunoassay Market Size by Technology & CAGR (2025-2032)

• Market Overview
• Electrochemical Detection
• Optical Detection

Global Microfluidic Immunoassay Market Size by Application & CAGR (2025-2032)

• Market Overview
• Cardiology
• Single Biomarker Detection
• Multiplexed Biomarker Detection
• Infectious Diseases
• Oncology
• Other Applications

Global Microfluidic Immunoassay Market Size by End User & CAGR (2025-2032)

• Market Overview
• Pharmaceutical & Biotechnology Companies
• Diagnostic Laboratories
• Hospital
• Other End Users

Global Microfluidic Immunoassay Market Size & CAGR (2025-2032)

• North America (Product, Technology, Application, End User)
  • US
  • Canada
• Europe (Product, Technology, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Technology, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Technology, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Technology, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Abbott Laboratories (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fluidigm Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GE Healthcare (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Illumina Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Luminex Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck Millipore (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Randox Laboratories Ltd. (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Diagnostics (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tosoh Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Wako Pure Chemical Industries, Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Waters Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations